These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7684297)
21. Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs. Bélichard P; Loillier B; Paquet JL; Luccarini JM; Pruneau D Br J Pharmacol; 1996 Apr; 117(7):1565-71. PubMed ID: 8730755 [TBL] [Abstract][Full Text] [Related]
22. Central involvement of kinin B1 and B2 receptors in the febrile response induced by endotoxin in rats. Coelho MM; Oliveira CR; Pajolla GP; Calixto JB; Pelá IR Br J Pharmacol; 1997 May; 121(2):296-302. PubMed ID: 9154340 [TBL] [Abstract][Full Text] [Related]
23. B2 receptor-mediated enhanced bradykinin sensitivity of rat cutaneous C-fiber nociceptors during persistent inflammation. Banik RK; Kozaki Y; Sato J; Gera L; Mizumura K J Neurophysiol; 2001 Dec; 86(6):2727-35. PubMed ID: 11731532 [TBL] [Abstract][Full Text] [Related]
24. Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin. Campos MM; Souza GE; Calixto JB Br J Pharmacol; 1996 Mar; 117(5):793-8. PubMed ID: 8851492 [TBL] [Abstract][Full Text] [Related]
25. Central nervous system kinin receptors and the hypertensive response mediated by bradykinin. Lindsey CJ; Nakaie CR; Martins DT Br J Pharmacol; 1989 Jul; 97(3):763-8. PubMed ID: 2547484 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats. Belichard P; Luccarini JM; Defrêne E; Faye P; Franck RM; Duclos H; Paquet JL; Pruneau D Br J Pharmacol; 1999 Sep; 128(1):213-9. PubMed ID: 10498854 [TBL] [Abstract][Full Text] [Related]
27. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins. Drapeau G; Audet R; Levesque L; Godin D; Marceau F J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550 [TBL] [Abstract][Full Text] [Related]
28. Bradykinin-induced biphasic response in the rat isolated stomach fundus: functional evidence for a novel bradykinin receptor. Calixto JB; Medeiros YS Life Sci; 1992; 50(7):PL47-52. PubMed ID: 1311792 [TBL] [Abstract][Full Text] [Related]
29. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors. MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157 [TBL] [Abstract][Full Text] [Related]
30. Effects of the bradykinin B1 receptor antagonist des-Arg9[Leu8]bradykinin and genetic disruption of the B2 receptor on nociception in rats and mice. Rupniak NM; Boyce S; Webb JK; Williams AR; Carlson EJ; Hill RG; Borkowski JA; Hess JF Pain; 1997 May; 71(1):89-97. PubMed ID: 9200178 [TBL] [Abstract][Full Text] [Related]
31. Up-regulation of [3H]-des-Arg10-kallidin binding to the bradykinin B1 receptor by interleukin-1 beta in isolated smooth muscle cells: correlation with B1 agonist-induced PGI2 production. Galizzi JP; Bodinier MC; Chapelain B; Ly SM; Coussy L; Giraud S; Neliat G; Jean T Br J Pharmacol; 1994 Oct; 113(2):389-94. PubMed ID: 7834189 [TBL] [Abstract][Full Text] [Related]
32. Induction of bradykinin B1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Perkins MN; Kelly D Br J Pharmacol; 1993 Dec; 110(4):1441-4. PubMed ID: 8306084 [TBL] [Abstract][Full Text] [Related]
33. The kinin B1 receptor antagonist des-Arg9-[Leu8]bradykinin: an antagonist of the angiotensin AT1 receptor which also binds to the AT2 receptor. Pruneau D; Duvoid A; Luccarini JM; Bélichard P; Bonnafous JC Br J Pharmacol; 1995 Jan; 114(1):115-8. PubMed ID: 7712006 [TBL] [Abstract][Full Text] [Related]
34. Characterization of kinin receptors modulating neurogenic contractions of the mouse isolated vas deferens. Maas J; Rae GA; Huidobro-Toro JP; Calixto JB Br J Pharmacol; 1995 Apr; 114(7):1471-7. PubMed ID: 7606350 [TBL] [Abstract][Full Text] [Related]
35. Metabolism of bradykinin analogs by angiotensin I converting enzyme and carboxypeptidase N. Drapeau G; Chow A; Ward PE Peptides; 1991; 12(3):631-8. PubMed ID: 1656406 [TBL] [Abstract][Full Text] [Related]
36. Autoradiographic localization of [125I-Tyr8]-bradykinin receptor binding sites in the guinea pig spinal cord. Lopes P; Kar S; Tousignant C; Regoli D; Quirion R; Couture R Synapse; 1993 Sep; 15(1):48-57. PubMed ID: 8310425 [TBL] [Abstract][Full Text] [Related]
37. Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors. Levesque L; Drapeau G; Grose JH; Rioux F; Marceau F Br J Pharmacol; 1993 Aug; 109(4):1254-62. PubMed ID: 8104648 [TBL] [Abstract][Full Text] [Related]
38. Bradykinin-induced airway microvascular leakage and bronchoconstriction are mediated via a bradykinin B2 receptor. Ichinose M; Barnes PJ Am Rev Respir Dis; 1990 Nov; 142(5):1104-7. PubMed ID: 2173456 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of bradykinin-induced bronchoconstriction in the guinea-pig by a synthetic B2 receptor antagonist. Jin LS; Seeds E; Page CP; Schachter M Br J Pharmacol; 1989 Jun; 97(2):598-602. PubMed ID: 2547478 [TBL] [Abstract][Full Text] [Related]